These results suggest that GBE may exert its neuroprotective and anti‐inflammatory effects by regulating the PI3K/AKT/NF‐κB signaling pathway, providing experimental evidence for its potential application in the treatment of neurodegenerative diseases. This evidence concerns the gene NFKB1 and neurodegenerative disease.